WEBSITE BSE:534927 NSE: ESTEEM BIO Inc. Year: 1995 Industry: Agriculture My Bucket: Add Stock
Last updated: 00:00
No Notes Added Yet
1. Business Overview
Esteem Bio Organic Food Processing Ltd. is an India-based company primarily engaged in the processing, trading, and supplying of a diverse range of organic food products. The company sources organic raw materials directly from farmers, processes them, and then distributes them under its brand (likely "Esteem Bio Organic" or similar, though not explicitly stated as their sole brand). Its product portfolio includes organic pulses (e.g., Toor, Moong, Urad), spices (e.g., Turmeric, Chilli, Coriander), flours (e.g., Wheat, Besan), rice, oils, dry fruits, jaggery, and sugar. The core business model revolves around meeting the growing demand for certified organic food products in the domestic market, leveraging direct sourcing and quality control. The company makes money through the sale of these processed organic food products to wholesalers, retailers, and potentially directly to consumers.
2. Key Segments / Revenue Mix
The company operates primarily within a single overarching segment: organic food processing and supply. While specific revenue contributions by product category (e.g., pulses vs. spices) are not publicly disclosed, their offerings are diversified across various kitchen staples. Given the nature of their business, the revenue mix is derived from the aggregated sales of their organic pulses, spices, flours, rice, oils, and other grocery items.
3. Industry & Positioning
Esteem Bio operates in the Indian organic food market, which is characterized by rapid growth driven by increasing health consciousness, rising disposable incomes, and government initiatives promoting organic farming. The industry is fragmented, with competition from larger established food companies diversifying into organic, numerous small and medium-sized organic brands, and direct-to-consumer organic farm models. Esteem Bio positions itself as a supplier of certified organic products, focusing on a wide range of essential commodities. As an SME-listed entity, it is a relatively smaller player compared to major national food corporations but aims to capture market share within the niche of authentic organic offerings.
4. Competitive Advantage (Moat)
As an SME in a competitive market, Esteem Bio's competitive advantages are likely developing rather than fully entrenched. Potential nascent moats could include:
Direct Sourcing Relationships: If they have established strong, reliable relationships with a network of organic farmers, it could ensure consistent supply and quality.
Certifications & Trust: Maintaining strict adherence to organic certification standards helps build consumer trust in a market where authenticity is paramount.
Product Diversification: Offering a wide array of organic staples could create a "one-stop shop" appeal for certain buyers.
However, a strong brand equity, significant scale advantages, or proprietary processing technology that creates durable pricing power or cost efficiency are not readily apparent at this stage.
5. Growth Drivers
Increasing Demand for Organic Products: Growing consumer awareness about health benefits and environmental concerns is fueling the demand for organic food in India.
Expansion of Product Portfolio: Introducing new organic product lines or value-added processed organic foods can broaden their market reach.
Geographic Expansion: Extending distribution networks to new regions within India or exploring export opportunities can drive sales volume.
Government Support: Initiatives promoting organic farming and food processing can create a favorable operating environment.
E-commerce & Organized Retail Growth: Leveraging online platforms and partnerships with modern retail chains can enhance market penetration.
6. Risks
Intense Competition: The organic food sector is becoming increasingly competitive, with larger, well-funded companies entering the space, potentially squeezing margins or market share.
Raw Material Sourcing Volatility: Dependence on organic farmers for raw materials exposes the company to risks of crop failure, price fluctuations, and supply chain disruptions.
Regulatory & Certification Risks: Maintaining stringent organic certifications is crucial, and any lapses or changes in regulations could impact business.
Consumer Price Sensitivity: Organic products often carry a premium, making them susceptible to shifts in consumer spending habits during economic downturns or if competitors offer lower prices.
Scale Limitations: As an SME, challenges related to capital for expansion, operational efficiency, and achieving economies of scale may exist.
Brand Building: The significant investment required to build and maintain a strong national brand in a crowded market.
7. Management & Ownership
The company is promoted by Mr. Devendra Kumar Jain and Ms. Priyanka Jain. As is typical for many SME-listed companies in India, the promoters likely hold a significant stake and are actively involved in the day-to-day management and strategic direction of the company. The ownership structure will reflect a high promoter holding, with the remaining shares held by the public and potentially a few high-net-worth individuals. Further details on individual management experience and specific ownership percentages would be available in their annual reports and BSE filings.
8. Outlook
Esteem Bio Organic Food Processing Ltd. operates in a sector with significant tailwinds, driven by India's burgeoning organic food market. The company's focus on a diverse product range and direct sourcing provides a foundation for growth. However, its small scale and the fragmented, competitive nature of the industry pose substantial challenges. Future success will heavily depend on its ability to consistently source high-quality organic raw materials, effectively manage its supply chain, scale up processing capabilities, build a recognizable and trusted brand, and navigate the competitive landscape while maintaining strict organic certifications and healthy profit margins. The potential for growth is present, but effective execution and capital management will be critical for sustained expansion.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹115 Cr.
Stock P/E 532.6
P/B 2.4
Current Price ₹4.6
Book Value ₹ 1.9
Face Value 1
52W High ₹0
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3 | 6 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 1 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 3 | 7 | 3 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 2 | |
| Total Expenditure | 0 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | |
| Operating Profit | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Tax | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
| Adjusted Earnings Per Share | 1.5 | 0.1 | 0.1 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0.1 | 0 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -67% | -31% | -24% | -10% |
| Operating Profit CAGR | -67% | -31% | -20% | -10% |
| PAT CAGR | -100% | -100% | -100% | -100% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 0% | 0% | -3% | -18% |
| ROE Average | 0% | 2% | 3% | 8% |
| ROCE Average | 1% | 3% | 3% | 7% |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 9 | 25 | 27 | 38 | 40 | 41 | 42 | 44 | 45 | 47 | 47 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 0 | 1 |
| Total Current Liabilities | 3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 2 |
| Total Liabilities | 12 | 26 | 30 | 42 | 43 | 43 | 45 | 48 | 49 | 49 | 50 |
| Fixed Assets | 6 | 12 | 12 | 17 | 18 | 17 | 16 | 15 | 14 | 13 | 12 |
| Other Non-Current Assets | 0 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Current Assets | 5 | 11 | 14 | 23 | 24 | 25 | 29 | 32 | 34 | 35 | 36 |
| Total Assets | 12 | 26 | 30 | 42 | 43 | 43 | 45 | 48 | 49 | 49 | 50 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 1 | 5 | 5 | 1 | 2 | 2 | 3 | 4 | 2 | 2 | 1 |
| Cash Flow from Investing Activities | -1 | -17 | -6 | -11 | -2 | -1 | -5 | -4 | -2 | -1 | -1 |
| Cash Flow from Financing Activities | -0 | 12 | 1 | 10 | 0 | -1 | 1 | 0 | -0 | -1 | 0 |
| Net Cash Inflow / Outflow | -0 | -1 | 0 | 1 | 0 | -0 | -1 | -0 | -0 | 0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.5 | 0.1 | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.05 | 0.08 | 0.01 |
| CEPS(Rs) | 1.5 | 0.13 | 0.1 | 0.12 | 0.13 | 0.11 | 0.11 | 0.11 | 0.09 | 0.1 | 0.03 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 4.35 | 1.03 | 1.1 | 1.53 | 1.58 | 1.63 | 1.69 | 1.77 | 1.82 | 1.89 | 1.9 |
| Core EBITDA Margin(%) | 96.74 | 46.86 | 73.44 | 81.47 | 85.59 | 73.23 | 76.26 | 77.92 | 81.74 | 87.23 | 46.36 |
| EBIT Margin(%) | 96.74 | 40.02 | 58.6 | 38.2 | 36.88 | 36.8 | 45.81 | 54.94 | 47.53 | 69.67 | 25.12 |
| Pre Tax Margin(%) | 96.73 | 40.01 | 58.59 | 38.19 | 36.86 | 36.72 | 45.79 | 54.92 | 47.51 | 69.66 | 25.08 |
| PAT Margin (%) | 96.73 | 39.65 | 57.51 | 36.16 | 33.96 | 35.03 | 44.14 | 53.25 | 46.21 | 68.47 | 18.22 |
| Cash Profit Margin (%) | 96.73 | 47.67 | 75.84 | 85.99 | 92.06 | 76.91 | 81.27 | 82.72 | 84.08 | 91.65 | 65.85 |
| ROA(%) | 27.93 | 13.41 | 6.57 | 3.43 | 2.84 | 2.85 | 3.23 | 3.89 | 2.44 | 3.9 | 0.44 |
| ROE(%) | 43.42 | 15.1 | 7.06 | 3.79 | 3.14 | 3.09 | 3.46 | 4.2 | 2.63 | 4.13 | 0.46 |
| ROCE(%) | 27.94 | 13.64 | 7.05 | 3.96 | 3.38 | 3.21 | 3.56 | 4.3 | 2.68 | 4.17 | 0.63 |
| Receivable days | 110.26 | 117.7 | 158.02 | 128.4 | 239.27 | 299.67 | 338.58 | 279.29 | 341.34 | 318.38 | 752.52 |
| Inventory Days | 352.7 | 99.34 | 30.68 | 27.67 | 48.56 | 60.09 | 59.33 | 40.01 | 32.85 | 38.54 | 88.26 |
| Payable days | 0 | 0 | 0 | -420.71 | -326.27 | 2289.09 | 1135.41 | 333.51 | 1672.77 | -346.87 | 228.59 |
| PER(x) | 0 | 30.38 | 443.27 | 465.59 | 954.38 | 699.6 | 330.73 | 128.16 | 114.62 | 0 | 564.37 |
| Price/Book(x) | 0 | 3.07 | 30.36 | 15.06 | 29.46 | 21.23 | 11.25 | 5.28 | 2.98 | 0 | 2.58 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.98 | 12.15 | 254.8 | 168.11 | 323.82 | 244.6 | 146.03 | 68.4 | 53.11 | 8.99 | 102.68 |
| EV/Core EBITDA(x) | 1.02 | 25.29 | 331.24 | 190.98 | 340.95 | 310.88 | 176.06 | 81.03 | 62.19 | 9.68 | 141.14 |
| Net Sales Growth(%) | 75.79 | 111.46 | -50.31 | 6.22 | 5.13 | -1.33 | -7.9 | 4.7 | -25.23 | 9.47 | -57.23 |
| EBIT Growth(%) | 37.4 | -12.52 | -27.24 | -30.76 | 1.49 | -1.54 | 14.64 | 25.57 | -35.32 | 60.48 | -84.58 |
| PAT Growth(%) | 37.4 | -13.32 | -27.92 | -33.21 | -1.27 | 1.77 | 16.04 | 26.3 | -35.12 | 62.22 | -88.62 |
| EPS Growth(%) | -77.1 | -93.03 | -27.96 | -34.22 | -1.27 | 1.69 | 16.13 | 26.39 | -35.16 | 62.29 | -88.64 |
| Debt/Equity(x) | 0.38 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| Current Ratio(x) | 1.66 | 14.09 | 17.01 | 17.28 | 15.91 | 15.97 | 19.11 | 19.45 | 18.44 | 27.62 | 22.33 |
| Quick Ratio(x) | 0.69 | 13.61 | 16.81 | 17.01 | 15.51 | 15.61 | 18.78 | 19.3 | 18.33 | 27.32 | 22.21 |
| Interest Cover(x) | 0 | 8521.3 | 8164.11 | 4212.14 | 2596.66 | 446 | 3131.04 | 2443.31 | 2543.1 | 5935.42 | 595.71 |
| Total Debt/Mcap(x) | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.